Ascension Ventures
The company’s flagship product, leva, is an FDA-cleared digital therapeutic that helps women strengthen their pelvic floor muscles to treat urinary incontinence.
Ascension Ventures and .406 Ventures joined the financing round that was led by Cigna Ventures and MemorialCare Innovation Fund.